财务
- Market Capitalization 11.48 M
- Employee 113
- Founded 2001
- CEO Yaky Yanay
- Website www.pluri-biotech.com
- Headquarter Nevada, United States
- FIGI BBG000DQX509
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.86
市销率
—
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4594 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.46 USD | -4.17% | -9.80% | -20.69% | -65.15% | 12.63 M USD | ||
| 4595 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 7.00 USD | -12.94% | -25.29% | -36.99% | +19.66% | 11.33 M USD | ||
| 4622 | PASG Passage Bio, Inc. - Common Stock | 3.68 USD | +1.10% | -3.66% | -21.70% | -58.37% | 11.84 M USD | ||
| 4623 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.24 USD | +0.24% | -6.47% | -5.18% | +428.21% | 11.56 M USD |